Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124652595 | 12465259 | 5 | F | 2016 | 20160801 | 20160614 | 20160810 | EXP | US-GILEAD-2016-0198932 | GILEAD | 53.00 | YR | A | F | Y | 0.00000 | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124652595 | 12465259 | 1 | PS | IDELALISIB | IDELALISIB | 1 | Oral | 150 MG, BID | Y | THSZA | 205858 | 150 | MG | CAPSULE | BID | ||||
| 124652595 | 12465259 | 2 | SS | IDELALISIB | IDELALISIB | 1 | Oral | 150 MG, BID | Y | THSZA | 205858 | 150 | MG | CAPSULE | BID | ||||
| 124652595 | 12465259 | 3 | SS | MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124652595 | 12465259 | 4 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124652595 | 12465259 | 5 | C | POTASSIUM | POTASSIUM | 1 | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124652595 | 12465259 | 1 | B-cell lymphoma |
| 124652595 | 12465259 | 3 | Constipation |
| 124652595 | 12465259 | 4 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124652595 | 12465259 | HO |
| 124652595 | 12465259 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124652595 | 12465259 | Abdominal pain upper | |
| 124652595 | 12465259 | Anal incontinence | |
| 124652595 | 12465259 | Anxiety | |
| 124652595 | 12465259 | Asthenia | |
| 124652595 | 12465259 | Constipation | |
| 124652595 | 12465259 | Decreased appetite | |
| 124652595 | 12465259 | Dehydration | |
| 124652595 | 12465259 | Diarrhoea | |
| 124652595 | 12465259 | Dizziness | |
| 124652595 | 12465259 | Dysgeusia | |
| 124652595 | 12465259 | Ear infection | |
| 124652595 | 12465259 | Emotional disorder | |
| 124652595 | 12465259 | Emotional distress | |
| 124652595 | 12465259 | Fatigue | |
| 124652595 | 12465259 | Feeling abnormal | |
| 124652595 | 12465259 | Feeling of despair | |
| 124652595 | 12465259 | Hyperhidrosis | |
| 124652595 | 12465259 | Hypotension | |
| 124652595 | 12465259 | Insomnia | |
| 124652595 | 12465259 | Lower respiratory tract congestion | |
| 124652595 | 12465259 | Lymphocyte count increased | |
| 124652595 | 12465259 | Malaise | |
| 124652595 | 12465259 | Nasopharyngitis | |
| 124652595 | 12465259 | Nausea | |
| 124652595 | 12465259 | Oropharyngeal pain | |
| 124652595 | 12465259 | Oxygen saturation decreased | |
| 124652595 | 12465259 | Peripheral swelling | |
| 124652595 | 12465259 | Pruritus | |
| 124652595 | 12465259 | Red blood cell count increased | |
| 124652595 | 12465259 | Sepsis | |
| 124652595 | 12465259 | Social avoidant behaviour | |
| 124652595 | 12465259 | Stomatitis | |
| 124652595 | 12465259 | Tearfulness | |
| 124652595 | 12465259 | Tongue discolouration | |
| 124652595 | 12465259 | Vision blurred | |
| 124652595 | 12465259 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124652595 | 12465259 | 1 | 20160210 | 20160519 | 0 | |
| 124652595 | 12465259 | 2 | 20160526 | 20160715 | 0 | |
| 124652595 | 12465259 | 3 | 20160229 | 0 | ||
| 124652595 | 12465259 | 4 | 2016 | 0 |